Skip to main content
Premium Trial:

Request an Annual Quote

Agena Bioscience, Molecular Health Partner for MassArray Interpretation

NEW YORK (GenomeWeb) – Agena Bioscience and Molecular Health said today that they have entered into a strategic partnership under which Molecular Health will use its MH Guide analysis platform to interpret raw data generated by Agena's MassArray system.

The relationship is part of Agena's MassArray Insights reporting network, under which the firm seeks to collaborate with various molecular analysis platform providers.

Specific terms of the agreement were not disclosed, but the firms said that they plan to "cooperate and collaborate with their respective customer bases."

According to Agena CEO Pete Dansky, Moleuclar Helath's data interpretation capabilities answer a currently unmet need for customers using the MassArray platform in the context of laboratory developed tests.

"Many of our customers with [LDTs] have been interested in additional resources for result interpretation. We believe that Molecular Health's data interpretation applications … can greatly streamline the data analysis and interpretation workflow for these customers," Dansky said in a statement.

Users of the MassArray system in the clinical testing sphere include Intermountain Healthcare and Assurex Health.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.